EventsEventsPodcasts
Loader
Find Us
ADVERTISEMENT

UK adds nerve disorder as rare side-effect of AstraZeneca COVID-19 vaccine

UK adds nerve disorder as rare side-effect of AstraZeneca COVID-19 vaccine
UK adds nerve disorder as rare side-effect of AstraZeneca COVID-19 vaccine Copyright Thomson Reuters 2021
Copyright Thomson Reuters 2021
By Reuters
Published on Updated
Share this articleComments
Share this articleClose Button

- The UK drug regulator added an extremely rare nerve-damaging disorder, Guillain-Barré syndrome (GBS), as a very rare side effect of the AstraZeneca COVID-19 vaccine, updates on the agency's website showed on Thursday.

Medicines and Healthcare products Regulatory Agency's (MHRA) decision comes after the European medicines agency added GBS as a possible side-effect last month.

Share this articleComments

You might also like

Chaos erupts among crowd following Trump's assassination attempt

Three people seriously injured after car rams bus stops in Israel

Euro 2024 Spain v England live: Latest updates from Berlin